Work:
Syntalogic Pharmaceuticals, Inc
Jan 2016 - Jul 2019
Advisor
Syntimmune
Nov 2013 - Nov 2018
Business Founder and Director-Acquired By Alexion Nov 2018
Syntimmune
Nov 2015 - Feb 2018
President and Chief Operations Officer
Columbia Business School
May 2013 - Jun 2017
Entrepreneur In Residence
Syntimmune
Nov 2013 - Nov 2015
Co-Founder, President and Chief Executive Officer
Kadmon Holdings, Inc.
Sep 2009 - Dec 2013
Senior Vice President
Syntonix Pharmaceuticals
1996 - 2007
Business Founder and Director
Blumberg Capital Management
1999 - 2006
Managing Member, Founder
Alliancebernstein
1994 - 1999
Vp, Equity Research
Syntalogic
1994 - 1999
Advisor
Education:
Columbia Business School 1993 - 1994
Master of Business Administration, Masters, Business
Abington Memorial Hospital 1987 - 1988
Temple University - Lewis Katz School of Medicine 1983 - 1987
Doctor of Medicine, Doctorates
Brandeis University 1981 - 1983
Bachelors, Bachelor of Arts, Physics
University of Pittsburgh 1979 - 1981
Cheltenham High School 1977 - 1979
Skills:
Biotechnology, Pharmaceutical Industry, Biopharmaceuticals, Lifesciences, Commercialization, Entrepreneurship, Life Sciences, Medical Devices, Healthcare, Venture Capital, Business Development, Start Ups, Licensing, Technology Transfer, Oncology, Drug Development, Strategy, Mergers and Acquisitions, Clinical Development, Management, Drug Discovery, Due Diligence, Clinical Trials, Corporate Development, Business Strategy, Cross Functional Team Leadership, Molecular Biology, Clinical Research, Immunology, Cancer, Regulatory Affairs, Pharmaceuticals, Product Launch, Competitive Intelligence, Market Analysis, Project Management, R&D, Vaccines, Hedge Funds, Managed Care, Pharmaceutical Sales, Fda, Market Research, Ctms, Cro, Neurology, Biochemistry, Start Up Ventures, Diabetes
